Medpace, Inc. Therapeutic Expert, Charles Schmidt, MD, PhD to Present at the Pediatric Drug Development and Clinical Trials in Brussels, November 17-18, 2009
11/10/2009 10:39:16 AM
More...
|
Medpace, Inc. Expands Therapeutic Capabilities With the Acquisition of Pharma Brains AG, a European CRO With Global Experience in Oncology Drug Development
11/2/2009 11:20:05 AM
More...
|
Amarin Corporation PLC (AMRN) Appoints Medpace, Inc. as CRO for Two Phase 3 Cardiovascular Trials
10/19/2009 8:38:24 AM
More...
|
Medpace, Inc. Therapeutic Expert, David G. Orloff, MD, to Present at the Next Drug Information Association (DIA) Conference, September 23-24, 2009
9/16/2009 10:44:37 AM
More...
|
Medpace, Inc. Announces the Addition of Patricia E. Cole, PhD, MD, Executive Director Imagepace, Strengthening Medpace Services in Clinical Imaging
8/20/2009 9:32:44 AM
More...
|
Medpace, Inc. Takes the Top Spot as the Best CRO for Overall Working Relationship as Rated by U.S. Investigative Sites in CenterWatch, 2009 Site Survey
6/3/2009 11:21:03 AM
More...
|
Medpace, Inc. Adds Medical Director, Dr. Fred Sauniere, MD, PhD, Strengthening Regulatory Expertise and Clinical Development Capabilities in Europe
3/10/2009 11:39:28 AM
More...
|
New Clinical Trial Customers Punctuate Success of Phase Forward-Medpace, Inc. Relationship
3/3/2009 10:39:53 AM
More...
|
Medpace, Inc. Adds Executive Medical Director, Dr. Thomas G. Todaro, MD, JD, FACC, FCLM, Strengthening Therapeutic Expertise in Cardiology
1/7/2009 9:48:06 AM
More...
|
Medpace, Inc. Strengthens Clinical Development Services With Medpace Bioanalytical Laboratories
12/16/2008 10:18:27 AM
More...
|
|